Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANDS

Anadys (ANDS)

Anadys Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANDS
DateTimeSourceHeadlineSymbolCompany
11/23/20113:10PMEdgar (US Regulatory)(25-NSE)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/23/20111:01PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/23/201112:39AMDow Jones NewsRoche Buys Shares In Tender Offer For Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/16/20115:02AMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/15/20114:10PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/14/20113:55PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/09/20115:05AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/09/20115:05AMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/08/20117:16AMMarketwiredAcquisition Spotlight Shines on Hepatitis C Drug DevelopersNASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/07/20114:01PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/07/20113:05PMPR Newswire (US)Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and HighlightsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
11/04/20113:34PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/31/20118:30AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/26/20117:16AMMarketwiredPositive Test Results and Acquisitions Drive Shares of Exelixis and Anadys HigherNASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/26/20115:02AMEdgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/25/20114:08PMEdgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/25/20113:25PMEdgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/25/20118:34AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/24/20113:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/21/20119:53AMBusiness WireThe Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/20/20112:39PMBusiness WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/20/20118:30AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/20/20115:08AMDow Jones NewsRoche MS Drug's Good Test Results Boost Pipeline's ProspectsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/19/20116:00PMBusiness WireFaruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/19/20114:14PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/19/20113:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/19/201112:12PMBusiness WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/18/201110:30PMBusiness WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/18/20118:00AMMarketwiredAnalyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LPNASDAQ:ANDSAnadys Pharmaceuticals (MM)
10/17/20117:32PMBusiness WireRobbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:ANDS